SMA THERAPIES I: P.178AVXS-101 phase 1 gene therapy clinical trial in spinal muscular atrophy type 1: improvement in respiratory and bulbar function reduces frequency and duration of hospitalizations compared to natural history. - Shell, R.; Al-Zaidy, S.; Arnold, W.; Rodino-Klapac, L.; Prior, T.; Kotha, K.; Paul, G.; Lowes, L.; Alfano, L.; Berry, K.; Church, K.; Kissel, J.; et al. (Neuromuscular Disorders, 2018)